Orion Health has an experienced Board of Directors, with diverse skills drawn from a range of industries.

  • Ian McCrae - Director and Chief Executive Officer
    Ian McCrae - Director and Chief Executive Officer

    Ian McCrae

    Director and Chief Executive Officer

    Ian founded Orion Health in 1993 with a four person staff in Auckland. Before this, Ian was a senior telecommunications consultant for Clearfield Consulting, specialising in message standards and connectivity of data network systems and infrastructures. Prior to his work at Clearfield, Ian worked for Ernst & Young designing corporate networks. Ian has also worked as a product manager at lmagineering Micro Distributors in New Zealand and as a senior business analyst for the London Stock Exchange.

    Ian holds a Masters in Engineering Sciences and a Bachelor of Engineering (Honours) from the University of Auckland. Previously, Ian was employed as a scientist by the NZDSIR and wrote mathematical models of the human body. Ian completed his Masters with a thesis utilising a combination of maths and software programming to model Antarctic ice shelves.

    Ian McCrae

    Director and Chief Executive Officer

  • Andrew Ferrier - Chairman and Independent Director
    Andrew Ferrier - Chairman and Independent Director

    Andrew Ferrier

    Chairman and Independent Director

    Andrew has held a number of director and executive positions for large multinationals and has 30 years of experience in international business. He has a strong background in growing businesses including 17 years as a CEO.

    From 2003 to 2011, Andrew was CEO of Fonterra Co-Operative Group, New Zealand's largest company. Prior to Fonterra, Andrew served as the President, Chief Executive Officer and director of GSW of Toronto, a manufacturer of consumer durable products and, prior to GSW, Andrew was President and CEO of Tate & Lyle North America Sugars of New York and President of Redpath Sugars in Toronto.

    Andrew currently runs his own investment company, Canz Capital, is Chairman of the New Zealand Government's economic development agency New Zealand Trade and Enterprise, sits on the Council of the University of Auckland and, in addition to Orion Health, sits on the boards of Bunge Ltd. in New York and Lufa Farms Inc. in Montreal, as well as other advisory and charitable boards.

    Andrew holds a Bachelor of Business Administration from the University of New Brunswick and a Master of Business Administration from Concordia University.

    Andrew Ferrier

    Chairman and Independent Director

  • Roger France - Deputy Chairman and Independent Director
    Roger France - Deputy Chairman and Independent Director

    Roger France

    Deputy Chairman and Independent Director

    Roger was the Chief Financial Officer of two listed companies for ten years (Allied Farmers Co-op and Freightways Holdings) followed by 15 years as a partner in PwC and one of its predecessor firms, Coopers & Lybrand. He was Managing Partner of Coopers & Lybrand Auckland for five years.

    He is a director of Air New Zealand, Fisher & Paykel Healthcare and Southern Cross Medical Care Society and a trustee of the University of Auckland Foundation and the Dilworth Trust Board. He is a member of The Treasury Commercial Operations Advisory Board.

    Roger holds a Bachelor of Commerce from the University of Canterbury and is a Fellow of both the Institute of Chartered Accountants Australia and New Zealand and the Institute of Directors in New Zealand.

    Roger France

    Deputy Chairman and Independent Director

  • Paul Shearer - Independent Director
    Paul Shearer - Independent Director

    Paul Shearer

    Independent Director

    Paul is the Senior Vice President of Sales & Marketing for Fisher & Paykel Healthcare, a global medical device manufacturer. Paul has over 25 years international experience working within the healthcare industry gained while managing and establishing FPH sales offices in North America, Europe and Asia. He is responsible for sales offices and employees in 35 countries. Paul is a Director of a number of Fisher & Paykel Healthcare subsidiaries and his prior experience includes positions held at ICL and Computercorp. He holds a Bachelor of Commerce from the University of Canterbury.

    Paul Shearer

    Independent Director

  • Neil Cullimore - Non-Executive Director
    Neil Cullimore - Non-Executive Director

    Neil Cullimore

    Non-Executive Director

    Neil has 50 years experience in the IT industry. Prior to 1993, he was CEO and director of Paxus Corporation, an Australian publicly listed IT company, Following the merger in 1993 of Paxus with The Continuum Company in Texas, he moved to become Executive Vice President of Continuum. In 1996 Continuum was acquired by Computer Sciences Corporation (CSC) and he became Executive Vice President of CSC's Financial Services Group.

    Since 1999, Neil has participated in a number of public and private companies in the IT industry both as an investor and director in New Zealand and Australia. Neil is a director of Culloden Investments and Heartland Investments and its associated subsidiaries in New Zealand and also HealthNet Investments in Australia. He is also an Operating Partner in Pioneer Capital.

    Neil holds a Bachelor of Science (Maths) from the University of Auckland.

    Neil Cullimore

    Non-Executive Director

  • Ronald Andrews - Independent Director
    Ronald Andrews - Independent Director

    Ronald Andrews

    Independent Director

    Ronald has close to 30 years in governance and executive roles in the US Clinical and Molecular Diagnostics industry. He sits on the Board of Directors for several companies, both public and private, and is active on a number of charitable boards. He has extensive experience working with the US government in Washington and speaks regularly to industry groups. 

    He served as the President of the Genetic Science Division for Thermo Fisher Scientific until December 2014. Prior to this he held a number of high profile executive roles including President of the Medical Sciences Venture within the Life Technologies Corporation, and he served as Chief Executive Officer of Clarient, a public company on the NASDAQ, which was sold to General Electric Healthcare in December 2010.”

    Ronald Andrews

    Independent Director

  • John Halamka.png
    John Halamka.png

    John Halamka

    Independent Director

    John is the International Healthcare Innovation professor at Harvard Medical School, where he has served in both Republican and Democrat presidential administrations, and advised national governments throughout the world on healthcare technology. He is also the chief information officer (CIO) at Beth Israel Deaconess Medical Center (BIDMC) and chairman of the New England Healthcare Exchange Network (NEHEN), as well as a practicing emergency physician.  

    In his role at BIDMC, John is responsible for all clinical, financial, administrative, and academic information technology, serving 3,000 doctors, 12,000 employees, and 1 million patients. As chairman of NEHEN, John oversees clinical and administrative data exchange among the insurers, healthcare providers, and patients in Massachusetts. He has authored five books on technology related issues, hundreds of articles and thousands of posts on the popular Geekdoctor blog. 

    John Halamka

    Independent Director

Governance Documents

Charters